Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Translational Histopathology Laboratory (THL), part of the Oxford Experimental Cancer Medicine Centre (ECMC), has achieved Good Clinical Laboratory Practice (GCLP) accreditation, marking an important milestone in the delivery of high-quality, standardised tissue analysis for the cancer research community in Oxford.

Data generated by the THL now meets internationally recognised quality and traceability standards,  a key step towards enabling more translational studies to move confidently from discovery to the clinic. GCLP accreditation also allows the THL to deliver analyses contributing to primary and secondary clinical trial endpoints.

The THL provides a comprehensive range of histopathology and digital pathology services, including:

  • Tissue processing, embedding, and sectioning
  • Haematoxylin and Eosin staining
  • Antibody optimisation and single or double chromogenic IHC
  • Slide scanning, automated tissue segmentation, and scoring
  • Tissue microarray construction
  • Multiplex immunofluorescence (5x colours panel) and imaging
  • Digital image analysis using the HALO® platform

Alongside technical capability,  the THL offers researchers access to pathology and digital pathology expertise. Dr Alistair Easton, pathologist and Senior Clinical Researcher in the Department of Oncology, is available to answer questions related to staining, tissue architecture and digital pathology analysis.

THL staff can advise on study design, antibody optimisation, and analysis strategies, helping researchers and clinicians obtain robust, reproducible data for both exploratory and regulated studies.

The ability to spatially interrogate markers on multiple samples has been game-changing for us, resulting in new scientific and clinical insights and the development of potential novel diagnostic tools. Without the support of the THL we would not have been able to generate such impactful data

Eileen Parkes, Associate Professor, Innate Tumour Immunology. 

The THL’s combination of accredited laboratory processes, expert pathology input, and advanced image analysis tools provides a unique resource within the Oxford research ecosystem. Whether supporting early-stage biomarker discovery or regulated clinical trials, the laboratory works closely with investigators to optimise protocols, standardise methods, and accelerate translational progress.

Researchers interested in discussing potential projects or seeking advice on pathology workflows are encouraged to contact the THL team to explore how the facility can support their studies.

Learn more on the THL webpage

Similar Stories

Oxford researchers win first and second place in MRC's 2025 Festive Science Image Competition.

2nd place was awarded to Nathalie Lövgren, DPhil Student, and Dr Iain Tullis, Senior Postdoctoral Researcher, in the Physics and Biology of FLASH Radiation Research Group at the University of Oxford. Nathalie and Iain's snowflake-inspired image was based on their work investigating a potential new radiation treatment for cancer.